SCHEMBL23615701

SCHEMBL23615701

O=C(CC1(O)C(=O)N(CCCc2c[nH]c3ccc(Cl)cc23)c2ccccc21)c1cccc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 9/20 0.51
▸ MAPT P10636 5/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51
▸ CBX7 O95931 2/20 0.49
▸ CDYL2 Q8N8U2 2/20 0.49
▸ CDYL Q9Y232 2/20 0.49
▸ CDY1; CDY1B Q9Y6F8 2/20 0.49
▸ ALDH1A1 P00352 5/20 0.46
▸ ACHE P22303 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SNCA P37840 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22761102 1.00 TP53 (0.51) TP53MAPTMEN1KMT2ALMNA
SCHEMBL23615678 0.94 TP53 (0.53) TP53MAPTMEN1KMT2ALMNA
SCHEMBL22761016 0.94 TP53 (0.53) TP53MAPTMEN1KMT2ALMNA
SCHEMBL22761094 0.93 TP53 (0.52) TP53MAPTMEN1KMT2ALMNA
SCHEMBL23615698 0.93 TP53 (0.52) TP53MAPTMEN1KMT2ALMNA
SCHEMBL23615669 0.93 TP53 (0.55) TP53MAPTMEN1KMT2ALMNA
SCHEMBL22761022 0.93 TP53 (0.55) TP53MAPTMEN1KMT2ALMNA
SCHEMBL23615754 0.92 CBX7 (0.51) TP53MAPTMEN1KMT2ALMNA
SCHEMBL22761256 0.92 CBX7 (0.51) TP53MAPTMEN1KMT2ALMNA
SCHEMBL23615746 0.91 TP53 (0.50) TP53MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634957-B1 NMDA RECEPTOR MODULATORS, COMPOSITIONS COMPRISING SAME AND USE OF THESE COMPOUNDS IN THE TREATMENT OF DISEASES INVOLVING THE CENTRAL NERVOUS SYSTEM ADPUERIVITAM (FR) 2021-07-07 — — EP disclosed
Send feedback